Related Experiment Video
Updated: Jul 4, 2026

12:24
Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
A structured light-based system for scanning subcutaneous tumors in laboratory animals
Ibrahim Cem Girit1, Maria Jure-Kunkel, Kim W McIntyre
1Biopticon Corporation, Plainsboro, NJ, USA. girit@comcast.net
Comparative Medicine
|July 1, 2008
Summary
A novel laser-scanning technology offers a high-throughput, accurate method for measuring tumor volume in preclinical drug studies. This system reduces errors and speeds up the evaluation of new anticancer drug candidates.
Area of Science:
- Oncology
- Drug Discovery
- Biomedical Engineering
Background:
- Tumor size is a key endpoint in preclinical anticancer drug efficacy studies.
- Current methods for high-throughput tumor volume measurement are often slow and inaccurate.
- Operator variability and bias can affect the reliability of existing techniques.
Purpose of the Study:
- To introduce a novel laser-scanning technology for high-throughput tumor measurement.
- To provide a more accurate and efficient method for assessing anticancer drug efficacy.
- To reduce interoperator variability and bias in tumor volume data collection.
Main Methods:
- Development and implementation of a laser-scanning system for tumor volume acquisition.
- Automated data collection, processing, and analysis capabilities.
- Comparison with existing methods to assess efficiency and accuracy.
Main Results:
- The laser-scanning system provides a convenient and high-throughput solution for tumor measurement.
- Significant reduction in interoperator variability and bias was observed.
- Automated data handling streamlines the evaluation of preclinical anticancer drug efficacy.
Conclusions:
- Laser-scanning technology offers a superior method for preclinical tumor volume assessment.
- This technology facilitates faster and more reliable evaluation of novel anticancer agents.
- The system enhances the efficiency and accuracy of drug discovery pipelines.

